ARS Pharmaceuticals Inc.
(SPRY)
undefined
undefined%
At close: undefined
12.05
1.13%
After-hours Dec 13, 2024, 07:09 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
Revenue | 30.00K | 1.32M | 5.51M | 17.84M | - | - |
Cost of Revenue | 73.00K | 17.32M | 20.27M | 14.07M | 1.55M | 1.42M |
Gross Profit | -43.00K | -16.00M | -14.77M | 3.77M | -1.55M | -1.42M |
Operating Income | -67.52M | -35.52M | -19.45M | -469.00K | -24.07M | -18.32M |
Interest Income | - | - | 800.00K | 400.00K | 100.00K | 43.00K |
Pretax Income | -54.37M | -34.68M | -20.24M | -1.06M | -23.97M | -17.58M |
Net Income | -54.37M | -33.99M | -20.24M | -1.06M | -23.97M | -17.58M |
Selling & General & Admin | 47.28M | 18.46M | 4.69M | 4.23M | 1.02M | 2.10M |
Research & Development | 20.27M | 18.38M | 20.27M | 14.07M | 21.50M | 14.80M |
Other Expenses | - | 974.00K | -789.00K | -596.00K | - | - |
Operating Expenses | 67.55M | 36.83M | 24.96M | 18.30M | 22.52M | 16.90M |
Interest Expense | - | - | 106.00K | 29.00K | - | - |
Selling & Marketing Expenses | - | - | - | - | - | - |
Cost & Expenses | 67.55M | 36.83M | 24.96M | 18.30M | 24.07M | 18.32M |
Income Tax | - | -694.00K | -230.56K | -200.30K | - | - |
Shares Outstanding (Basic) | 95.22M | 39.96M | 28.87M | 34.70M | 33.07M | 33.07M |
Shares Outstanding (Diluted) | 95.22M | 39.96M | 28.87M | 34.70M | 33.07M | 33.07M |
EPS (Basic) | -0.57 | -0.85 | -0.7 | -0.03 | -0.72 | -0.53 |
EPS (Diluted) | -0.57 | -0.85 | -0.7 | -0.03 | -0.72 | -0.53 |
EBITDA | -67.45M | -35.52M | -19.24M | -463.00K | -22.52M | -16.90M |
Depreciation & Amortization | 73.00K | 319.00K | 213.00K | 1.71M | 1.55M | 1.42M |